+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors

Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors

Pathology International 59(12): 851-856

The aim of the present study was to compare the efficiency of tissue microarray (TMA) results using immunohistochemistry markers applied to a variety of core sizes and full sections of gastrointestinal stromal tumors (GIST) using performance measures such as core loss rate and concordance rate. Six primary antibody markers (c-Kit, CD34, smooth muscle actin (SMA), S-100, p53, and Ki-67) were used with the TMA technique to analyze 0.6 mm, 2 mm, and 3 mm punch cores of GIST samples from 67 patients. No statistical association was found between core size and loss rate (P= 0.512). TMA results for the 0.6 mm, 2 mm, and 3 mm core showed that all core sizes could statistically significantly reflect full sections with regard to c-Kit, SMA, and S-100 antibodies, but that the 3 mm core section was the most representative except for CD34. With regard to p53 and Ki-67 staining, the 0.6 mm core section was not representative, but the 2 mm and 3 mm core sections could statistically significantly represent full section results. Among them, the 3 mm core section was more accurate than the 2 mm core section. Use of a single 3 mm core size in TMA is suitable for evaluating large numbers of protein and nuclear stains with regard to immunohistochemistry for GIST.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052249060

Download citation: RISBibTeXText

PMID: 20021609

DOI: 10.1111/j.1440-1827.2009.02465.x

Related references

Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors. Pathology International 60(11): 707-713, 2010

Canine Gastrointestinal Spindle Cell Tumors Efficiently Diagnosed by Tissue Microarray-Based Immunohistochemistry. Veterinary Pathology 55(5): 678-681, 2018

Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors. Gastric Cancer 17(1): 87-96, 2014

Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clinical Cancer Research 11(2 Pt 1): 638-645, 2005

Immunohistochemistry of gastrointestinal stromal tumors. Laboratory Investigation 54(1): 51A, 1986

The Immunohistochemistry of Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology 11(6): 464-473, 1987

A comparison of the efficacy and safety of endoscopic full-thickness resection and laparoscopic-assisted surgery for small gastrointestinal stromal tumors. Surgical Endoscopy 30(8): 3357-3361, 2016

The diagnostic value of immunohistochemistry in gastrointestinal stromal tumors. Virchows Archiv 435(3): 170, 1999

Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update. Seminars in Diagnostic Pathology 32(5): 392-399, 2015

Histomorphology and Immunohistochemistry of Gastrointestinal Stromal Tumors in a Malaysian Population. Asian Pacific Journal of Cancer Prevention 17(6): 2795-2799, 2016

Study on gastrointestinal stromal tumors by electron microscopy and immunohistochemistry. Zhonghua Bing Li Xue Za Zhi 32(2): 101-105, 2003

Gastrointestinal stromal tumors Diagnosis by fine needle aspiration and immunohistochemistry. Acta Cytologica 44(5): 909, September-October, 2000

Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors. Hepato-Gastroenterology 50(53): 1431-1435, 2003

Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?. Asian Pacific Journal of Cancer Prevention 14(8): 4751-4758, 2013

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. American Journal of Surgical Pathology 34(5): 636-644, 2010